NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 86 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $42,000 | -65.3% | 22,500 | -10.4% | 0.00% | – |
| Q4 2021 | $121,000 | -36.6% | 25,100 | -4.9% | 0.00% | – |
| Q3 2021 | $191,000 | -21.7% | 26,400 | 0.0% | 0.00% | – |
| Q2 2021 | $244,000 | -10.6% | 26,400 | +18.9% | 0.00% | – |
| Q1 2021 | $273,000 | -20.9% | 22,200 | -9.4% | 0.00% | – |
| Q4 2020 | $345,000 | +17.3% | 24,500 | 0.0% | 0.00% | – |
| Q3 2020 | $294,000 | -6.4% | 24,500 | +29.6% | 0.00% | – |
| Q2 2020 | $314,000 | – | 18,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,156,200 | $10,672,000 | 1.77% |
| ACT CAPITAL MANAGEMENT, LLC | 239,000 | $2,207,000 | 1.13% |
| EcoR1 Capital, LLC | 2,358,804 | $21,772,000 | 0.81% |
| Redmile Group, LLC | 3,919,235 | $36,175,000 | 0.54% |
| Boxer Capital, LLC | 1,501,058 | $13,855,000 | 0.49% |
| Baker Brothers Advisors | 3,821,740 | $35,275,000 | 0.16% |
| Sio Capital Management, LLC | 38,312 | $354,000 | 0.09% |
| Highland Private Wealth Management | 46,999 | $434,000 | 0.06% |
| PERSONAL CFO SOLUTIONS, LLC | 23,710 | $219,000 | 0.04% |
| Point72 Asset Management, L.P. | 883,102 | $8,151,000 | 0.04% |